Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STELLA: CertiroBell + Tacrolimus in Liver Transplant
NCT04867720Phase 4Unknown
- Sponsor
- Chong Kun Dang Holdings
- Start
- Mar 2021
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in Liver transplant rejection, sponsored by Chong Kun Dang Holdings. Status: unknown.
02
Drugs
everolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT04867720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04867720.